Morphic Medical logo — Innovative therapies for type 2 diabetes and obesity, rooted...

Morphic Medical

Innovative therapies for type 2 diabetes and obesity, rooted in excellence since 2003.

Founded 2003 United States Boston, United States 50 employees Post Ipo Equity Total: $200.35M Biotechnology, Health Care +2

General Information

Company Name Morphic Medical
Founded Year 2003
Location United States Boston, United States
Employees 50
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Post Ipo Equity
Social

Get notified when Morphic Medical moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Morphic Medical

Morphic Medical, formerly known as GI Dynamics Inc., is a pioneer in developing innovative therapies for type 2 diabetes and obesity. The company's flagship product, RESET® (EndoBarrier), is an endoscopically delivered device therapy that provides a non-surgical alternative for treating type 2 diabetes and obesity. It is important to note that RESET is currently limited to investigational use only and is not approved for sale in the United States. Founded in 2003, Morphic Medical is based in Boston, Massachusetts, and operates within the Biotechnology, Health Care, Health and Wellness, and Medical Devices sectors. In August 2019, the company secured a significant $10.00M Post-IPO Equity investment from Crystal Amber. The focus on non-surgical therapies for type 2 diabetes and obesity positions Morphic Medical as an emerging player in the healthcare innovation space, with potential for impactful growth and value creation.

Taxonomy: Medical Device, Endoscopic Therapy, Type 2 Diabetes Treatment, Obesity Treatment, Metabolic Diseases Therapy, Non-Surgical Treatment, Device Therapy, EndoBarrier, Innovative Therapies, Medical Innovation, Clinical Research, Non-Surgical Alternative, Medical Device Development, Medical Research

Funding Rounds & Investors (13)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity $10.00M 1 Crystal Amber 23 Aug 2019
Post-IPO Equity $5.00M - 20 Sep 2018
Post-IPO Equity $1.80M - 08 May 2018
Post-IPO Equity $2.05M - 22 Jan 2018
Post-IPO Debt $5.00M - 15 Jun 2017

View All 13 Funding Rounds

Morphic Medical Alternatives & Competitors

Morphic Medical vs

Treating Tumor and Arthritis

Series Unknown
7 employees
Health Care
Morphic Medical vs

Introducing the next generation microwave ablation device for cancer treatment

Series A
10 employees
Health Care, Medical Devices
Morphic Medical vs
OncoBeta
OncoBeta Germany

Painless, Non-Invasive, Non-Melanocytic Skin Cancer Therapy

33 employees
Health and Wellness, Medical Devices

FAQ About Morphic Medical

Innovative therapies for type 2 diabetes and obesity, rooted in excellence since 2003.
Morphic Medical was founded in 2003.
Morphic Medical is headquartered in Boston, United States.
Morphic Medical operates in the following industries: Biotechnology, Health Care, Health and Wellness, Medical Devices.
Morphic Medical has approximately 50 employees.
Morphic Medical has completed 13 funding rounds, raising a total of $200.35M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Morphic Medical include SBF Healthcare, HEPTA Medical, OncoBeta, Reset IV, Alpheus Medical, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Morphic Medical and SBF Healthcare are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Morphic Medical and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy